Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 54,321 |
|
|||||
| News | - | ||||||
| Day High | 18.0513 | Low High |
|||||
| Day Low | 17.45 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Kiniksa Pharmaceuticals Ltd | KNSA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.25 | 1.42% | 17.86 | 11:47:25 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 17.84 | 17.45 | 18.0513 | 17.61 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,280 | 54,321 | $ 17.93 | $ 973,917 | - | 10.645 - 22.10 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:52:59 | 5 | $ 17.85 | USD |
Kiniksa Pharmaceuticals Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.27B | 70.62M | - | 270.26M | 14.08M | 0.20 | 89.92 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Kiniksa Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KNSA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 16.87 | 18.61 | 16.56 | 17.48 | 453,997 | 0.99 | 5.87% |
| 1 Month | 19.64 | 19.73 | 16.56 | 17.70 | 374,317 | -1.78 | -9.06% |
| 3 Months | 18.10 | 22.10 | 16.56 | 19.40 | 377,584 | -0.24 | -1.33% |
| 6 Months | 15.25 | 22.10 | 14.12 | 18.19 | 431,580 | 2.61 | 17.11% |
| 1 Year | 11.03 | 22.10 | 10.645 | 17.19 | 434,445 | 6.83 | 61.92% |
| 3 Years | 16.41 | 22.10 | 7.36 | 14.23 | 392,564 | 1.45 | 8.84% |
| 5 Years | 15.94 | 33.00 | 5.01 | 15.31 | 354,424 | 1.92 | 12.05% |
Kiniksa Pharmaceuticals Description
| Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; Vixarelimab; and KPL-404. |
